Global

Is Synergy Pharmaceuticals Inc. (SGYP) Investing Its Way Into A Muddle?

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) gained 2.47% in yesterday’s session, going up from its prior closing price of $3.24 to $3.32 The stock price went upward in 5 of the last 10 days and has generated 28.19% during the last two weeks. The upbeat movement of both volume and price during the recent session is interpreted as a good sign, and, overall 0.04 million more shares exchanged hands compared with prior day. In total, 5.27 M shares exchanged hands for about $17.50 million.

Inside SGYP’s Recent Trend

Synergy Pharmaceuticals Inc. (SGYP) lies the upper part of a very wide and falling trend in the short term, and this will normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break down through the support point at $3.37 will initially suggest a lower tendency for declines in the price and this might very well be an early sign that a trend shift is coming. Short-term traders are anticipated to see a retreat of -29.05% over the course of a quarter and, with 90% chance the price will be floating in the range of $1.40 and $2.39 in this timeframe.

Synergy Pharmaceuticals Inc. Technical Signals



SGYP has witnessed its short term MA triggering a sell signal. Meanwhile, however, the long-term average has generated a buy signal. When the short-run moving average rises above its longer-term trend, a buy signal is created. This is because a short-run moving average that crosses its long-run moving average counterpart is seen as the initiation of an upward trend. On additional rally, the share price will meet short term resistance at around $3.38. On a drop, the stock is likely to find some support over the long run, which begins at $2.94. A buy signal will be generated if it crosses above the short term moving average. Meanwhile, however, a price crossing below the long term moving average will generate a sell signal. Its pivot point low generated buy signal on Wednesday October 11, 2017, which calls for additional surge until the stock forms a new pivot point high. There was increase in both volume and price. This is usually interpreted as a good sign as traders widely believe rising stock should see increasing volume.

Synergy Pharmaceuticals Inc. (NASDAQ:SGYP) Support And Resistance Levels

In case of pullback, the next support the price will capture from accumulated volume will not be far away from current price at $3.07 and $2.98. In case of gains, the next resistance from accumulated volume will not be far away from today’s level at $3.44, $3.46 and $3.88.




It is important to note, however, that the stock needs to make its way through natural risk while testing a key support level. Once this support is broken, another support level will be to be established at a lower level. Turning back to this stock, Synergy Pharmaceuticals approaches the first support point just current price at $3.07. In case of a break, the next support we will see from accumulated volume is going to be at $2.98 and $2.90. Accumulated volume is going to prevent the price from rising further at $3.44 and this action will lead the price to take a temporary pause or stay muted for a few days.

Synergy Pharmaceuticals Inc. (SGYP) Risk Assessment

A volatility based measure Bollinger Bands suggests this stock poses high risk. In the most recent session, the stock price hovered around $0.17 between high and low, or 5.38%. The average volatility for the past week stood at 4.70%.

The stock is in overbought condition based on RSI(14) readings and sits at the top end of the trend. In general, this offers great exit point for the short term traders. The RSI above 70 combined with the trend position poses greater risk so increased volatility should be expected. The stock correction is due. The decline may accelerate to the downside in the near term but it is reasonable to consider what the key support levels may be that would support a bounce back to the upside for stock.

Previous ArticleNext Article

Related Post

Which of these 2 stocks can turn out to be absolut... The shares of Radian Group Inc. have increased by more than 15.35% this year alone. The shares recently went up by 4.38% or $0.87 and now trades at $2...
Comparing ITUS Corporation (ITUS) and Marathon Pat... ITUS Corporation (NASDAQ:ITUS) shares are down more than -46.30% this year and recently increased 10.27% or $0.27 to settle at $2.90. Marathon Patent ...
Drilling Down Into the Books for SCANA Corporation... SCANA Corporation (NYSE:SCG) is an interesting stock at present. Now trading with a market value of 10.34B, the company has a mix of catalysts and obs...
Should You Invest in Altaba Inc. (AABA)? A Look at... Recent insider trends for Altaba Inc. (NASDAQ:AABA) have caught the attention of investors. Analysts study insider data to get a sense of sense of wha...
Freeport-McMoRan Inc. (NYSE:FCX): Can the Bear Run... Freeport-McMoRan Inc. (NYSE:FCX) fell by -2.23% in Tuesday’s trading session from $15.27 to $14.93 The stock price went upward in 6 of the last 10 day...